ArticleThe Journal of dermatology2024

Comparative study of efficacy and safety: Biosimilar rituximab versus originator rituximab in the treatment of pemphigus.

Sang Heon Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.